```html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>PPROM Clinical Guidelines</title>
<style>
  body { font-family: Arial, sans-serif; }
  .container { display: flex; justify-content: space-between; }
  .left-column { width: 30%; padding: 20px; background-color: #f8f8f8; }
  .right-column { width: 65%; padding: 20px; }
  h2 { color: #333; }
  ul { list-style-type: none; padding: 0; }
  li { padding: 8px; border-bottom: 1px solid #ddd; }
</style>
</head>
<body>
<div class="container">
  <div class="left-column">
    <h2>Variables</h2>
    <ul>
      <li>Maternal history</li>
      <li>Sterile speculum examination</li>
      <li>IGFBP-1/PAMG-1 test</li>
      <li>Erythromycin administration</li>
      <li>Corticosteroids administration</li>
      <li>Chorioamnionitis assessment</li>
      <li>Magnesium sulfate administration</li>
      <li>Expectant management</li>
    </ul>
  </div>
  <div class="right-column">
    <h2>Guidance</h2>
    <p><strong>Diagnosis of PPROM:</strong> Based on maternal history followed by a sterile speculum examination. Consider IGFBP-1 or PAMG-1 test if no amniotic fluid is observed.</p>
    <p><strong>Antibiotic Treatment:</strong> Administer erythromycin for 10 days or until the woman is in established labor.</p>
    <p><strong>Corticosteroids:</strong> Offer to women with PPROM between 24+0 and 33+6 weeks' gestation.</p>
    <p><strong>Chorioamnionitis Diagnosis:</strong> Use clinical assessment, maternal blood tests, and fetal heart rate monitoring.</p>
    <p><strong>Magnesium Sulfate:</strong> Offer to women in established labor with PPROM between 24+0 and 29+6 weeks for neuroprotection.</p>
    <p><strong>Expectant Management:</strong> Continue until 37+0 weeks for women with PPROM after 24+0 weeks' gestation.</p>
  </div>
</div>
</body>
</html>
```